Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 19

Showing 19 citing articles:

CD38 regulates ovarian function and fecundity via NAD+ metabolism
Rosalba Perrone, Prasanna Vadhana Ashok Kumaar, Lauren Haky, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107949-107949
Open Access | Times Cited: 22
Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes
Amin Ullah, Yongxiu Chen, Rajeev K. Singla, et al.
Pharmacological Research (2024) Vol. 204, pp. 107213-107213
Open Access | Times Cited: 8
Diagnostic Value of NLR and PLR for Malignancy in Ovarian Tumor: Feasible Markers in Low-resource Setting
Ardhanu Kusumanto, Muhammad Ary Zucha, Siti Salima, et al.
Journal of South Asian Federation of Obstetrics and Gynaecology (2025) Vol. 16, Iss. S3, pp. S229-S233
Closed Access
Racial Differences in Vaginal Fluid Metabolites and Association with Systemic Inflammation Markers among Ovarian Cancer Patients: A Pilot Study
Oyomoare L. Osazuwa‐Peters, April Deveaux, Michael J. Muehlbauer, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1259-1259
Open Access | Times Cited: 2
Incessant ovulation: a review of its importance in predicting cancer risk
Daniel W. Cramer
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian Cancer
Rafał Watrowski, Eva Schuster, Toon Van Gorp, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10272-10272
Open Access | Times Cited: 1
Pelvic inflammatory disease and risk of borderline ovarian tumors: A national population‐based case–control study in Sweden
Sarah Jonsson, Håkan Jönsson, Eva Lundin, et al.
International Journal of Cancer (2024)
Open Access | Times Cited: 1
Endometrial cell‑derived exosomes facilitate the development of adenomyosis via the IL‑6/JAK2/STAT3 pathway
Xinchan Jiang, Xiaobo Chen
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 4
A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
Wen‐Ying Chen, Hanyuan Liu, Xinya Huang, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107712-107712
Open Access | Times Cited: 3
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer
David Standing, Prasad Dandawate, Sumedha Gunewardena, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access
New Trends in Ovarian Cancer Diagnosis Using Deep Learning: A Systematic Review
Mohamed El-Khatib, Dan Popescu, Oana Mihaela Teodor, et al.
IEEE Access (2024) Vol. 12, pp. 116587-116608
Open Access
Aging affects regrowth of stealthperitoneal dissemination of advanced ovarian cancer: a multicenter retrospective cohort study
Hiroki Fujimoto, Masato Yoshihara, Carmela Ricciardelli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma
Fabian Ullrich, Paul J. Bröckelmann, Amin T. Turki, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009462-e009462
Open Access
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Hina Amer, Nirmala Chandralega Kampan, Catherine Itsiopoulos, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4187-4187
Open Access
CD38 regulates ovarian function and fecundity via NAD+metabolism
Rosalba Perrone, Prasanna Vadhana Ashok Kumaar, Lauren Haky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer
Jian Xiong, Yiyuan Fu, Jiezheng Huang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer
David Mysona, Sharad Purohit, Katherine P. Richardson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Platelet to Lymphocyte Ratio as a Predictive Tool for the Perioperative and Postoperative Outcomes in Advanced Stage Ovarian Cancer
Irina Bălescu, Iulian Brezean, Victor Cauni, et al.
Chirurgia (2023) Vol. 118, Iss. 4, pp. 417-417
Open Access
IRAK1 is a critical mediator of low molecular weight hyaluronic acid-induced stemness in high-grade serous ovarian cancer
David Standing, Prasad Dandawate, Sumedha Gunewardena, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top